Rainbow BioSciences, LLC: NASA Bioreactor Could Speed Parkinson's Research
Published: Oct 04, 2012
NOKOMIS, Fla.--(BUSINESS WIRE)--Stem cell research may hold the key to a cure for Parkinson’s disease. The only problem is, stem cell research hasn’t advanced as quickly as patients need it to. Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp. (OTCBB: RBCC) is working to market an advanced stem cell growth solution that could potentially energize the worldwide search for a cure. Currently, government restrictions and ethical dilemmas serve as roadblocks to fast-paced stem cell research, but even when these roadblocks are absent, controlling the behavior of stem cells in a laboratory isn’t easy. One way to help speed research projects up and make them more efficient is to raise the number of high-quality adult stem cells available for that research.